Reduced sodium pump α1, α3, and β1-isoform protein levels and Na+, K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure

Circulation

Volumn 99, Issue 16, 1999, Pages 2105-2112

  Schwinger, Robert H G ^b   Wang, Jiangnan ^a   Frank, Konrad ^c   Müller Ehmsen, Jochen ^c   Brixius, Klara ^c   McDonough, Alicia A ^a   Erdmann, Erland ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c NONE

Author keywords

Heart failure; Myocardium; Receptors; Sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CARDIAC GLYCOSIDE; ISOENZYME; POTASSIUM ION; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; ION EXCHANGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SARCOLEMMA;

EID: 0033609089     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.16.2105     Document Type: Article

References (35)

1. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336: 525-533.
2. Schwinger RHG, Böhm M, Erdmann E. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors. J Cardiovasc Pharmacol. 1990;15:692-697.
3. Schwinger RHG, Böhm M, Mittmann C, La Rosee K, Erdmann E. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium. J Mol Cell Cardiol. 1991;23:461-471.
4. +-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res. 1993;27:2229-2237.
5. +-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium. J Pharmacol Exp Ther. 1996;276:1180-1188.
6. 2+-exchanger in human myocardium. Br J Clin Pharmacol. 1997;43:399-405.
7. Smith TW. Digitalis, mechanisms of action and clinical use. N Engl J Med. 1988;318:358-365.
8. Lee CO, Abete P, Pecker M, Sonn JK, Vassalle M. Strophanthidin inotropy: role of intracellular sodium ion activity and sodium-calcium exchange. J Mol Cell Cardiol. 1985;17:1043-1053.
9. +-channel activators. Am Heart J. 1996;131:988-993.
10. +-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977;29:187-220.
11. +-ATPase isoforms in myocardium. Circ Res. 1994;74:669-678.
12. +-ATPase in human heart. Biochim Biophys Acta. 1993;1149:189-194.
13. 2+-exchanger in the human heart. J Clin Invest. 1996;98:1650-1658.
14. +-ATPase expression in normal and failing human left ventricle. Basic Res Cardiol. 1992;87(suppl 1):87-94.
15. 2+-exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
17. +-ATPase: immunocytochemical localization along nephron segments. Kidney Int. 1985;28:899-913.
18. +-ATPase have distinct antigenic determinants. J Biol Chem. 1985;260:9016-9022.
19. +-ATPase. Am J Physiol. 1992;262: C743-C751.
20. +-ATPase in the rat embryo tissues, inner ear, and choroid plexus. Biol Cell. 1994;81: 215-222.
21. 2+-exchanger protein. Biochim Biophys Acta. 1988;945:298-306.
22. Porzig H, Li Z, Nicoll DA, Philipson KD. Mapping of the cardiac sodium-calcium exchanger with monoclonal antibodies. Am J Physiol. 1993;265:C748-C756.
23. 2+-exchanger: hypertension, thyroid hormone, development. Am J Physiol. 1995;269:C675-C682.
24. Dixon TF, Purdom M. Serum 5′ nucleotidase. J Clin Pathol. 1954;7: 341-351.
25. +-ATPase preparations from different tissues and species: determination of kinetic constants and dissociation constants. Biochim Biophys Acta. 1973; 307:386-398.
26. +-stimulated hydrolysis of adenosine triphosphate. Eur J Biochem. 1967;1:334-343.
27. Schwinger RHG, Böhm M, Müller-Ehmsen J, Uhlmann R, Schmidt U, Stäblein A, Überfuhr P, Kreuzer E, Reichart B, Eissner HJ, Erdmann E. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation. 1993;88:2267-2276.
28. Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51:660-672.
29. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-657.
30. +-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol. 1988;61:1312-1315.
31. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB. Beta 1-and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
32. Schwinger RHG, Böhm M, Pieske B, Erdmann E. Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest. 1991;21:443-451.
33. 2+ exchanger in failing human myocardium. Circulation. 1996;94:992-1002.
34. 2+-exchanger cDNA. Proc Natl Acad Sci U S A. 1992;89:4769-4773.
35. +-ATPase a isoform expression in heart and vascular endothelia: cellular and developmental regulation. Am J Physiol. 1996;270:C361-C371.